Skip to main content
OpenTrials
Completed

NCT Number: NCT07137676

Monitoring and Cognitive Appraisal: The Etiology of Psychological Disorders and The Divergence Between Behavioural and Self-reported Data

The study investigates the etiology of psychogical disorders from a neuropsychological perspective based on monitoring and cognitive appraisal.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Geriatric Patients in a Pre-rehabilitative Treatment Cognition Disorders Cognitive Dysfunction Mental Disorders Mild Cognitive Impairment (MCI) Neurocognitive Disorders

Age range

65 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

St. Franziskus-Hospital Winterberg

Winterberg, North Rhine-Westphalia, 59955, Germany

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • geriatric patient of the St. Franziskus-Hospital, Germany.

Exclusion criteria

  • severe dementia
  • delirium
  • psychotic disorders

Treatment and study plan

AX-CPT

Behavioral

administration of the AX-CPT

No interventions

Other

Control group with no intervention treatment

Primary outcomes

  1. AX-CPT (AX-Continuous Performance Test)

    Time frame: from beginning (day 2) of the hospitalization to the end (day 14) of the biweekly pre-rehabilitative treatment.

    The AX-CPT assesses cognitive control through error rates and reaction times. Range: Error rate: 0-100%; Reaction time: measured in milliseconds Interpretation: Lower error rates and faster reaction times indicate better cognitive control performance.

  2. CCFQ (Cognitive Control and Flexibility Questionnaire)

    Time frame: Day 1 (pretest) and Day 14 (posttest)

    The CCFQ measures self-reported cognitive flexibility and control.

    Scale title: Cognitive Control and Flexibility Questionnaire Range: 1-7 per item Interpretation: Higher scores indicate greater cognitive flexibility and control.

  3. BSI-18 (Brief Symptom Inventory - 18)

    Time frame: Day 1 (pretest) and Day 14 (posttest)

    T he BSI-18 assesses psychological symptom severity in terms of depression, anxiety, and somatization.T

    Scale title: Brief Symptom Inventory - 18 Range: 0-4 per item Interpretation: Higher scores indicate greater symptom severity.

  4. MHC-SF (Mental Health Continuum - Short Form)

    Time frame: Day 1 (pretest) and Day 14 (posttest)

    Measures emotional, psychological, and social well-being. Range: 1-6 per item Interpretation: Higher scores indicate better mental health.

Secondary outcomes

  1. General Self-Efficacy assessed via General Self-Efficacy Scale (SWE)

    Time frame: Day 1 (pretest) and Day 14 (posttest)

    Evaluation of perceived self-efficacy across various life domains. Range: 1-4 per item Interpretation: Higher scores indicate greater self-efficacy.

  2. Treatment Beliefs assessed via Palermo Questionnaire

    Time frame: Day 1 (pretest) and Day 14 (posttest)

    Beliefs and expectations regarding treatment effectiveness. Range: 1-5 per item Interpretation: Higher scores indicate stronger and more positive treatment beliefs.

Sponsors and collaborators

Lead sponsor

St. Franziskus Hospital

Other

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Aug 22, 2025
Registry last updated
Aug 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.